How do you mix hMG?
Draw to
unitsmL
0.3 mL · 30 units syringe0.5 mL · 50 units syringe1 mL · 100 units syringe3 mL · 3cc syringe0.5 mL · 20 units, U-40 syringe1 mL · 40 units, U-40 syringe
IU is how the drug is measured; units are the marks on the syringe. The draw is the dose in IU divided by the IU in each mL, times 100 on a U-100 syringe or 40 on a U-40. Every figure comes from what you enter.
Save to Milligram
Open in Milligram shows once the calculator has a result.
Open in Milligram is off while the dose is more than the whole vial. Check the dose and its unit.
Open in Milligram is off while the draw is under one unit. Check the dose and its unit.
Open in Milligram adds HMG and this dose to a plan in the app, with the schedule you pick here. The vial and water are not saved.
The US instructions give 1 mL of 0.9% saline as the usual amount to mix a 75 IU Menopur vial, or the amount a healthcare provider gives, added in full and swirled, not shaken, and the UK SmPC says 1 ml of the mixed 75 IU product contains 75 IU.12
The guide's example
75 IU of HMG (Human Menopausal Gonadotropin) from a 150 IU vial mixed with 1 mL is 50 units on a U-100 syringe. The 50 is the syringe's mark, not IU.
Every vial at a glance. Pick a cell to draw it on the syringe.
Vial strengths and water
The US label describes a vial as 75 IU of FSH and 75 IU of LH activity, supplied with a diluent vial of 2 mL of 0.9% sodium chloride.1 The 150 IU row matches the UK 150 IU product, whose 1 ml of mixed solution contains 150 IU, or two 75 IU vials in 1 ml, and the largest row is three 75 IU vials: the UK SmPC allows up to 3 vials in 1 ml of the solvent, while the US instructions say a dose may need more than 1 vial and the syringe liquid can mix up to 5 more vials.321
Mixing a vial and reading the syringe
The US instructions say to add all of the saline in the syringe to the powder and swirl, not shake.1 Once the powder has dissolved, the same instructions say to push the air out of the syringe, turn the vial upside down and slowly withdraw all of the Menopur; for further vials, the liquid just mixed is used to mix the next vial.1 The sources give no syringe marks, so the marks below come from the concentration alone: the UK 150 IU product's 1 ml of mixed solution holds 150 IU, and 75 IU, the lower menotrophin dose in the UK SmPC male infertility regimen, is read off that.3
75 IU of HMG (Human Menopausal Gonadotropin) from a 150 IU vial mixed with 1 mL is 50 units on a U-100 syringe. The 50 is the syringe's mark, not IU.
What the label and trials give for dose
For ovulatory women in an assisted reproductive technology cycle, the US label gives an initial starting dose for the first cycle of 225 IU a day by subcutaneous injection, adjusted after 5 days by no more than 150 IU at each adjustment, to a ceiling of 450 IU a day.1 It limits therapy to 20 days.1 The UK SmPC for the 75 IU product gives an initial 75-150 IU daily for at least 7 days for anovulatory infertility, which it lists for women who have been unresponsive to clomiphene citrate, and 150-225 IU daily for at least the first 5 days for women undergoing controlled ovarian hyperstimulation for assisted reproductive technologies.2 It says the dosage is adjusted individually depending on the ovarian response: in anovulatory infertility by 37.5 IU per adjustment, not over 75 IU, to a maximum of 225 IU daily, and in assisted reproduction by no more than 150 IU per adjustment, to a maximum of 450 IU daily, with dosing beyond 20 days generally not recommended.2
The US label's indication is ovulatory women only, and the pack found no label or trial for bodybuilding, cycle, post-cycle or TRT use of hMG; the one related source is the Menon 2003 case report of a single bodybuilder whose azoospermia persisted 1 year off steroids.14 No human trial in the pack reports an hMG dose for men on testosterone replacement or for healthy men; in the Shah 2021 retrospective cohort of thirty-five men with congenital hypogonadotropic hypogonadism, 18 had had prior TRT and those without it had a significantly higher peak sperm count (median 9 vs 0.05 million/ml).5
| Trial | Dose and schedule | People | Length |
|---|---|---|---|
| Shah, 2021 retrospective cohort5 | hMG 75-150 U three times a week with hCG escalated until a maximum of 2000 U 3/week or 5000 U 2/week, or a serum total testosterone of ≥ 3.5 ng/ml, was reached | Thirty-five men with congenital hypogonadotropic hypogonadism, 18 with prior TRT and 17 without | 33 ± 12 months |
| Liu, 2021 comparative study6 | hCG with hMG, doses not given here | Male adolescents with congenital hypogonadotropic hypogonadism: 20 on hCG/hMG, 21 on a GnRH pump | Study phase 0-3 months, follow-up 3-12 months |
| Zhao, 2019 randomised, double-blinded, placebo-controlled study7 | hCG/hMG against placebo, doses not stated | Men with idiopathic oligozoospermia, number not stated | 3 months per arm |
Where hMG is injected
The US label says to inject subcutaneously in the abdomen, 1-2 inches below the navel, alternating sides.1 The UK SmPC gives the same dosing by intramuscular or subcutaneous use.2
Storage before and after mixing
The US label says the powder may be stored refrigerated or at room temperature, 3° to 25° C, until dispensed, protected from light.1 Both labels say to use the mixed product immediately and discard the rest.12 The pack found no multi-day stability data for mixed Menopur in the US label or in the two UK SmPCs it searched.
Frequently asked questions
Can bacteriostatic water be used?
The UK SmPC says the powder is only to be reconstituted with the solvent provided in the package.2 The pack has nothing naming bacteriostatic water for hMG.
- HMGLabel data and studies for hMG.
- HMG calculatorMixing calculator for hMG.
- Post-cycle and ancillariesThe wider group hMG sits in.
- CyclesHow cycles are laid out.
- HCG dosage for menThe hCG that male trials gave with hMG.
- Anastrozole dose on TRTA related guide.
- Cialis while on cycleA related guide.
- Mixing a vialThe general steps.
References
- Ferring Pharmaceuticals (DailyMed). These highlights do not include all the information needed to use MENOPUR ® safely and effectively. See full prescribing information for MENOPUR. MENOPUR ® (menotropins) for injection, for subcutaneous use. Initial U.S. Approval: 1975. 2018. dailymed.nlm.nih.gov
- electronic medicines compendium (UK SmPC). Menopur 75IU Powder and solvent for solution for injection - Summary of Product Characteristics (SmPC) - print friendly - (emc). medicines.org.uk
- electronic medicines compendium (UK SmPC). Menopur 150 IU Powder and Solvent for Solution for Injection - Summary of Product Characteristics (SmPC) - print friendly - (emc). medicines.org.uk
- PubMed. Successful treatment of anabolic steroid-induced azoospermia with human chorionic gonadotropin and human menopausal gonadotropin. 2003. pubmed.ncbi.nlm.nih.gov
- PubMed. Prior testosterone replacement therapy may impact spermatogenic response to combined gonadotropin therapy in severe congenital hypogonadotropic hypogonadism. 2021. pubmed.ncbi.nlm.nih.gov
- PubMed Central. Efficacy and safety of human chorionic gonadotropin combined with human menopausal gonadotropin and a gonadotropin-releasing hormone pump for male adolescents with congenital hypogonadotropic hypogonadism. 2021. pmc.ncbi.nlm.nih.gov
- PubMed. Treatment of idiopathic oligozoospermia with combined human chorionic gonadotropin/human menopausal gonadotrophin: A randomised, double-blinded, placebo-controlled clinical study. 2019. pubmed.ncbi.nlm.nih.gov